Literature DB >> 20924553

[Imaging of molecular structures of breasts with new sonography techniques].

M Reisegger1, G Schueller, R Gruber, K Pinker, C Riedl, T H Helbich.   

Abstract

Sonography has become one of the most important imaging methods in breast diagnostics. Through the development of high-frequency transducers and the use of ultrasound contrast agents, the number of indications for sonography of the breast has continued to increase in recent years. Visualization of very small vessels under 100 µm enables sensitive detection and quantification of tissue perfusion. Thus, breast ultrasound can play an essential role in answering questions about certain pathologies. Further technical advances, such as automated breast ultrasound systems, provide an essential step for standardization of investigations. Targeted ultrasound is a new important development of this technique. Specific markers which are conjugated with the surface of contrast medium microspheres allow targeted molecular endothelial structures to be selectively visualized and quantified. These developments will strengthen the role of sonography in the future as a non-invasive and easy to use method.

Mesh:

Substances:

Year:  2010        PMID: 20924553     DOI: 10.1007/s00117-010-2013-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  39 in total

1.  Contrast ultrasound in breast tumor characterization: present situation and future tracks.

Authors:  H Madjar
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.

Authors:  S Huber; T Helbich; J Kettenbach; W Dock; I Zuna; S Delorme
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

3.  Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors.

Authors:  Joachim Kettenbach; Thomas H Helbich; Sabine Huber; Ivan Zuna; Wolfgang Dock
Journal:  Eur J Radiol       Date:  2005-02       Impact factor: 3.528

4.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.

Authors:  Gregory E R Weller; Flordeliza S Villanueva; Eric M Tom; William R Wagner
Journal:  Biotechnol Bioeng       Date:  2005-12-20       Impact factor: 4.530

5.  Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.

Authors:  W K Moon; J G Im; D Y Noh; M C Han
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

6.  Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1.

Authors:  Beat A Kaufmann; John M Sanders; Christopher Davis; Aris Xie; Patrick Aldred; Ian J Sarembock; Jonathan R Lindner
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

7.  Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.

Authors:  Shin-Ho Kook; Hyon-Joo Kwag
Journal:  J Clin Ultrasound       Date:  2003-06       Impact factor: 0.910

8.  Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography.

Authors:  Ayşegül Zdemir; Koray Kiliç; Hakan Ozdemir; Cem Yücel; Sebnem Andaç; Meriç Colak
Journal:  J Ultrasound Med       Date:  2004-02       Impact factor: 2.153

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.